3 ms·
> I mean jesus for the first time ever, a company is going to put up a drug for approval to treat alzheimers. Derek Lowe isn't quite so optimistic about it: ht
by jcranmer 7y ago
> I mean jesus for the first time ever, a company is going to put up a drug for approval to treat alzheimers.
Derek Lowe isn't quite so optimistic about it: https://blogs.sciencemag.org/pipeline/archives/2019/10/23/the-return-of-aducanumab https://blogs.sciencemag.org/pipeline/archives/2019/10/23/th...
(tl;dr--the anti-amyloid hypothesis you should be extremely skeptical about, and the inconsistency in the trial data here is signalling that statistical fluke should be a high concern).
- dekhn 7y agoif you really want to read more, check out https://www.baybridgebio.com/blog/aducanumab-analysis.html https://www.baybridgebio.com/blog/aducanumab-analysis.html There's a reason I went back to being a software engineer at an internet company working on ML models that actually work- clinical trials have a long way to go before they produce results that can be really trusted.